Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Addex Therapeutics (ADXN) Interest Expenses (2022 - 2025)

Historic Interest Expenses for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$1021.3.

  • Addex Therapeutics' Interest Expenses rose 9258.1% to -$1021.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $4066.3, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $4031.9 for FY2024, which is 9887.25% down from last year.
  • Latest data reveals that Addex Therapeutics reported Interest Expenses of -$1021.3 as of Q3 2025, which was up 9258.1% from $7039.6 recorded in Q2 2025.
  • Addex Therapeutics' Interest Expenses' 5-year high stood at $294446.3 during Q4 2022, with a 5-year trough of -$12.9 billion in Q4 2023.
  • Moreover, its 4-year median value for Interest Expenses was -$1021.3 (2025), whereas its average is -$859.6 million.
  • As far as peak fluctuations go, Addex Therapeutics' Interest Expenses tumbled by 437927522.52% in 2023, and later skyrocketed by 83681.63% in 2025.
  • Quarter analysis of 4 years shows Addex Therapeutics' Interest Expenses stood at $294446.3 in 2022, then crashed by 4379275.23% to -$12.9 billion in 2023, then skyrocketed by 100.0% to $19347.7 in 2024, then crashed by 105.28% to -$1021.3 in 2025.
  • Its last three reported values are -$1021.3 in Q3 2025, $7039.6 for Q2 2025, and -$21299.6 during Q1 2025.